RISK FACTORS FOR DEVELOPING RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS AFTER IMMUNOTHERAPY WITH IMMUNE CHECKPOINT INHIBITORS

被引：0
|
作者：
Liapi, M. [1 ]
Chatzidionysiou, K. [1 ]
机构：
[1] Karolinska Inst, Rheumatol Div, Dept Med Solna, Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Malignancy;
D O I：
10.1136/annrheumdis-2023-eular.6181
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1638
引用
收藏
页码：2053 / 2054
页数：2
相关论文
共 50 条
  • [41] Evaluation of Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer
    Simonaggio, Audrey
    Michot, Jean Marie
    Voisin, Anne Laure
    Le Pavec, Jerome
    Collins, Michael
    Lallart, Audrey
    Cengizalp, Geoffray
    Vozy, Aurore
    Laparra, Ariane
    Varga, Andrea
    Hollebecque, Antoine
    Champiat, Stephane
    Marabelle, Aurelien
    Massard, Christophe
    Lambotte, Olivier
    JAMA ONCOLOGY, 2019, 5 (09) : 1310 - 1317
  • [42] Rheumatic Immune-Related Adverse Events Associated with Treatment with Immune Checkpoint Inhibitors: A Multicenter Study of 38 Cases
    Rodriguez-Garcia, Sebastian
    Lobo, David
    Ojeda, Fabiola
    Castellanos-Moreira, Raul
    Laiz, Ana
    Gumucio, Roberto
    Diaz-Torne, Cesar
    Ruiz-Esquide, Virginia
    Milian, Milena
    Castellvi, Ivan
    Moya Alvarado, Patricia
    Magallares, Berta
    Perez, Carolina
    Corominas, Hector
    Gomez-Puerta, Jose
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors
    Fukushima, Taito
    Kobayashi, Satoshi
    Ueno, Makoto
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (09) : 949 - 958
  • [44] Vitamin D, autoimmunity and immune-related adverse events of immune checkpoint inhibitors
    Sun, Lillian
    Arbesman, Joshua
    Piliang, Melissa
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2021, 313 (01) : 1 - 10
  • [45] Biomarkers associated with immune-related adverse events induced by immune checkpoint inhibitors
    Guo, An-Jie
    Deng, Qing-Yuan
    Dong, Pan
    Zhou, Lian
    Shi, Lei
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2024, 15 (08):
  • [46] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [47] IMMUNE-RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS IN SPANISH PATIENTS
    Villalobos, L.
    Giraldo-sifuentes, W. A.
    Moran-alvarez, P.
    Arroyo Palomo, J.
    Briones-figueroa, A.
    Rita, C.
    Morell-hita, J. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 511 - 511
  • [48] Cutaneous Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors and Their Management
    Pach, J.
    Leventhal, J. S.
    CRITICAL REVIEWS IN IMMUNOLOGY, 2022, 42 (04) : 1 - 20
  • [49] EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
    Kostine, Marie
    Finckh, Axel
    Bingham, Clifton O., III
    Visser, Karen
    Leipe, Jan
    Schulze-Koops, Hendrik
    Choy, Ernest H.
    Benesova, Karolina
    Radstake, Timothy R. D. J.
    Cope, Andrew P.
    Lambotte, Olivier
    Gottenberg, Jacques-Eric
    Allenbach, Yves
    Visser, Marianne
    Rusthoven, Cindy
    Thomasen, Lone
    Jamal, Shahin
    Marabelle, Aurelien
    Larkin, James
    Haanen, John B. A. G.
    Calabrese, Leonard H.
    Mariette, Xavier
    Schaeverbeke, Thierry
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (01) : 36 - 48
  • [50] Rheumatic Immune-Related Adverse Events-A Consequence of Immune Checkpoint Inhibitor Therapy
    Bobirca, Anca
    Bobirca, Florin
    Ancuta, Ioan
    Florescu, Alesandra
    Padureanu, Vlad
    Florescu, Dan Nicolae
    Padureanu, Rodica
    Florescu, Anca
    Musetescu, Anca Emanuela
    BIOLOGY-BASEL, 2021, 10 (06):
12345